Most kidney disease cannot be cured in the traditional sense, but the outlook depends entirely on what type you have. Acute kidney injury, caused by a sudden event like dehydration or a medication reaction, often recovers fully with treatment. Chronic kidney disease (CKD), where the kidneys lose function gradually over months or years, is a different story: lost kidney tissue doesn’t regenerate, so the goal shifts to slowing or stopping further damage. In early stages, the right combination of medication, diet, and lifestyle changes can keep kidney function stable for decades. In advanced stages, dialysis or a transplant can take over the work your kidneys can no longer do.
Acute vs. Chronic: Why the Type Matters
Acute kidney injury happens fast, sometimes over just a few days. Common triggers include severe dehydration, infections, blood pressure drops during surgery, or medications that are toxic to the kidneys. Treatment focuses on fixing whatever caused the damage: replacing fluids, adjusting medications, or using temporary dialysis to filter waste while the kidneys heal. Most people recover in the hospital, though how long that takes depends on the underlying cause. This is the scenario closest to a true “cure,” because the kidneys can bounce back once the trigger is removed.
Chronic kidney disease is different. It develops over months or years, usually driven by high blood pressure, diabetes, or an autoimmune condition. Once kidney tissue is scarred, it doesn’t repair itself. That distinction is critical: CKD management is about protecting whatever function remains, not restoring what’s been lost.
The Five Stages of Chronic Kidney Disease
CKD is classified by how well your kidneys filter blood, measured by a number called GFR (glomerular filtration rate). A normal GFR is 90 or above. The stages break down like this:
- Stage 1 (GFR 90+): Normal filtering, but signs of kidney damage like protein in the urine
- Stage 2 (GFR 60–89): Mildly decreased function
- Stage 3a (GFR 45–59): Mild to moderate loss
- Stage 3b (GFR 30–44): Moderate to severe loss
- Stage 4 (GFR 15–29): Severe loss
- Stage 5 (GFR below 15): Kidney failure
A GFR reading alone doesn’t define CKD. At stages 1 and 2, you need evidence of actual kidney damage (typically protein in the urine) for a diagnosis. This matters because many people with a slightly low GFR don’t actually have kidney disease. The amount of protein leaking into your urine, measured by a number called the albumin-to-creatinine ratio, is the other key marker. A ratio under 30 is normal; 30 to 300 signals moderate damage; above 300 is severe.
What Slows Kidney Disease Down
The most effective approach combines blood pressure control, blood sugar management (if you have diabetes), and specific medications that protect the kidneys. A class of drugs originally designed for diabetes has become one of the biggest advances in kidney care. These medications, called SGLT2 inhibitors, reduce the risk of kidney disease progression by roughly 18% to 36% depending on whether you have diabetes. They work even in people without diabetes, which has expanded who benefits from them significantly.
Blood pressure medications that target a hormone system called the renin-angiotensin system have been a cornerstone of CKD treatment for years. They reduce pressure inside the kidney’s tiny filtering units, which slows scarring. Keeping blood pressure below target (usually around 120/80 for most people with CKD) is one of the single most important things you can do to preserve function.
For people with diabetes, tight blood sugar control matters enormously. Diabetes is the leading cause of kidney failure worldwide, and even modest improvements in blood sugar levels reduce the strain on your kidneys over time.
How Diet Affects Kidney Function
What you eat plays a surprisingly large role in CKD management. For people in stages 3 through 5 who don’t have diabetes, guidelines recommend limiting protein intake to about 0.55 to 0.60 grams per kilogram of body weight per day. For a 150-pound person, that’s roughly 37 to 41 grams of protein daily, which is significantly less than most people eat. If you have diabetes and CKD stages 3 through 5, the recommended range is slightly higher: 0.6 to 0.8 grams per kilogram per day.
Why protein? Your kidneys have to work harder to process protein’s waste products. Reducing intake eases that workload. Research shows that protein restriction lowers the risk of progressing to kidney failure and can improve quality of life. But this needs to be done under supervision, because cutting protein too aggressively can cause malnutrition. A kidney dietitian can help you find the right balance and identify which foods to adjust.
Beyond protein, you may also need to limit sodium (to control blood pressure and fluid retention), potassium, and phosphorus, especially in later stages. The specifics depend on your lab results, which is why regular blood work matters.
Dialysis: What It Looks Like in Practice
When kidneys lose enough function that waste builds up dangerously, dialysis takes over the filtering job. There are two main types. Hemodialysis uses a machine to clean your blood, typically three times a week for about four hours per session at a dialysis center (though home hemodialysis is an option too). Peritoneal dialysis uses the lining of your abdomen as a natural filter; you fill your abdominal cavity with a special fluid, let it absorb waste, then drain it. This can be done at home, often overnight while you sleep.
Survival rates between the two methods are broadly similar. Peritoneal dialysis tends to show equal or slightly better survival in the first one to two years, particularly for younger patients and those without diabetes. For older patients with diabetes, hemodialysis may have a slight edge over time. The choice often comes down to lifestyle: peritoneal dialysis offers more flexibility and independence, while hemodialysis at a center means trained staff handle the process.
Dialysis isn’t a cure. It replaces one function of the kidneys (filtering waste), but it doesn’t replicate everything kidneys do, like producing hormones that regulate red blood cell production or activate vitamin D. People on dialysis still need medications to fill those gaps.
Kidney Transplants
A kidney transplant is the closest thing to a cure for kidney failure. A healthy kidney from a living or deceased donor takes over full filtering duties, and most recipients no longer need dialysis. The results have improved dramatically over the past two decades. A transplant from a living donor now lasts a median of 19.2 years, up from 12.1 years for transplants done in the late 1990s. Deceased donor transplants last a median of 11.7 years, up from 8.2 years over the same period.
The trade-off is that you’ll need to take anti-rejection medications for as long as the transplanted kidney functions. These drugs suppress part of your immune system to prevent it from attacking the new organ, which increases your risk of infections and certain cancers over time. Even so, transplant recipients generally live longer and report better quality of life than people who stay on dialysis.
The biggest barrier to transplantation is organ availability. Wait times for a deceased donor kidney average three to five years in the United States, depending on your blood type and region. Living donor transplants skip much of that wait, which is one reason they tend to have better outcomes: the kidney spends less time without blood flow before being implanted.
Experimental Approaches on the Horizon
Stem cell therapy has generated interest as a potential way to repair kidney tissue. A recent analysis pooling data from four human studies found that stem cell treatment modestly improved kidney filtration rates and reduced markers of kidney damage in people with diabetic kidney disease. However, these trials were small (90 total participants), and while animal studies suggest stem cells can promote repair of certain kidney cells, there’s no evidence yet that they can regenerate the kidney’s filtering units in humans.
Researchers at the University of California, San Francisco, are developing an implantable bioartificial kidney designed to be surgically placed inside the body and work continuously, eliminating the need for dialysis sessions. The device hasn’t entered human trials yet. The team estimates it’s two to three years from being technically ready for clinical testing, with a goal of commercial availability by 2030, though funding gaps could push that timeline back.
Neither of these approaches is available as a standard treatment today. For now, the most effective path remains early detection, aggressive management of blood pressure and blood sugar, the newer kidney-protective medications, and dietary changes that reduce the strain on remaining kidney tissue. Caught early enough, many people with CKD live full lives without ever reaching the point of needing dialysis or a transplant.